Artelo Biosciences, Inc. (ARTL)
NASDAQ: ARTL · Real-Time Price · USD
2.960
-0.120 (-3.90%)
May 6, 2026, 9:35 AM EDT - Market open
Artelo Biosciences Market Cap
Artelo Biosciences has a market cap or net worth of $2.78 million as of May 6, 2026. Its market cap has decreased by -17.03% in one year.
Market Cap
2.78M
Enterprise Value
2.97M
1-Year Change
-17.03%
Ranking
Category
Stock Price
$2.96
Market Cap Chart
Since November 14, 2017, Artelo Biosciences's market cap has decreased from $5.88M to $2.78M, a decrease of -52.74%. That is a compound annual growth rate of -8.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 5, 2026 | 2.89M | 17.32% |
| Dec 31, 2025 | 2.46M | -28.01% |
| Dec 31, 2024 | 3.42M | -23.37% |
| Dec 29, 2023 | 4.46M | -45.90% |
| Dec 30, 2022 | 8.25M | -62.41% |
| Dec 31, 2021 | 21.95M | 99.02% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 21, 2017 | Upgrade Pro | Upgrade Pro |
| Nov 14, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GeoVax Labs | 3.73M |
| Soligenix | 3.45M |
| GRI Bio | 3.42M |
| Decoy Therapeutics | 3.14M |
| Valion Bio | 2.88M |
| HCW Biologics | 2.78M |
| Oragenics | 2.67M |
| Virax Biolabs Group | 2.51M |